Barclays maintains Hold for Great-West Lifeco stock with CAD 104.91 consensus target
Published on 10/14/2026 at 15:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and quarterly figures
- Barclays maintained its Hold rating on October 7, 2026, while the consensus target was CAD 104.91.
- Second-quarter 2026 revenue reached CAD 12.72 billion and net profit was CAD 1.09 billion.
- Great-West Lifeco stock costs EUR 56.46 at Lang & Schwarz on October 14, 2026 at 2:41 p.m. CEST, up 1.05 percent on the TSX.
- The price-to-earnings ratio was 18.47, and the next earnings date is November 4, 2026.
Great-West Lifeco (ISIN CA39138C1068) was priced at EUR 56.46 at Lang & Schwarz on October 14, 2026 at 2:41 p.m. CEST, with the TSX quote up 1.05 percent on the session. According to Markets Insider on October 7, 2026, Barclays maintained a Hold rating, while the consensus target stood at CAD 104.91. That target was 17.11 percent above the TSX price of CAD 89.58 on October 13, 2026.
Second-quarter figures widened
Great-West Lifeco reported CAD 12.72 billion in revenue for the second quarter of 2026, compared with CAD 10.39 billion a year earlier. Net profit reached CAD 1.09 billion, versus CAD 927.00 million in the second quarter of 2025, according to Markets Insider.
The companys own investor-relations page describes operations across Canada, the United States and Europe through Canada Life, Empower and Irish Life. The mix gives the earnings profile exposure to insurance, retirement savings, wealth management and reinsurance rather than a single product line.
Stock remains below yearly high
On the TSX, Great-West Lifeco last stood at CAD 89.58 on October 13, 2026 at 4:00 p.m. EDT, versus CAD 88.65 at the prior close. The 52-week range was CAD 57.56 to CAD 95.96, placing the quote 6.65 percent below its high and 55.63 percent above its low.
Market capitalization was CAD 80.2 billion on October 13, 2026. The price-to-earnings ratio was 18.47 and the trailing dividend yield was 3.00 percent, figures that place valuation alongside the companys recent earnings expansion rather than apart from it.
Valuation and next results date
Simply Wall St lists November 4, 2026 as the next earnings date. The same source identifies insider selling as a risk, while its October 6, 2026 analysis raised a fair-value estimate to CAD 75.60 from CAD 73.77.
Comparison with peers
Great-West Lifeco: plus 1.05 percent, P/E 18.47, market capitalization CAD 80.2 billion
Manulife Financial (TSX, CAD): plus 1.67 percent, P/E 16.64, market capitalization CAD 102.7 billion
Sun Life Financial (TSX, CAD): plus 0.92 percent, P/E 18.78, market capitalization CAD 61.4 billion
Trading price and range
At Lang & Schwarz, Great-West Lifeco stock was trading at EUR 56.46 on October 14, 2026 at 2:41 p.m. CEST, up 1.05 percent on the TSX. The TSX quote was CAD 89.58 on October 13, 2026, with CAD 95.96 as the 52-week high and CAD 57.56 as the low. The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.
Great-West Lifeco market data
- Company: Great-West Lifeco Inc.
- ISIN: CA39138C1068
- Ticker: GWO
- Primary exchange: TSX
- Price Lang & Schwarz (as of October 14, 2026, 2:41 p.m. CEST): EUR 56.46
- Change on TSX versus prior close (October 13, 2026): plus 1.05 percent
- Prior close on TSX (October 12, 2026): CAD 88.65
- Market capitalization: CAD 80.2 billion (as of October 13, 2026)
- 52-week range: CAD 57.56-CAD 95.96 (as of October 13, 2026)
- Sector / Industry: Financials / Life and health insurance
- Next earnings date: November 4, 2026
Market context: Market report S&P/TSX Composite.
